Table 2. Characteristics of the subgroup patients with atrial fibrillation.
| Variables | Anticoagulation | CHA2DS2-VASc score ≥ 2 | |||||
|---|---|---|---|---|---|---|---|
| Yes (n = 58) | No (n = 35) | p-value | No (n = 36) | Yes (n = 57) | p-value | ||
| Age (years) | 65 ± 9 | 65 ± 9 | 0.697 | 65 ± 10 | 65 ± 9 | 0.986 | |
| Female sex | 46 (79.3) | 26 (74.3) | 0.574 | 30 (83.3) | 42 (73.7) | 0.278 | |
| Prior stroke | 9 (15.5) | 2 (5.7) | 0.198 | 4 (11.1) | 7 (12.3) | 0.999 | |
| Anticoagulation | 58 (100) | 0 (0) | - | 20 (55.6) | 38 (66.7) | 0.281 | |
| CHA2DS2-VASc score | 2.4 ± 1.6 | 2.2 ± 1.6 | 0.111 | 0.8 ± 0.4 | 3.2 ± 1.3 | < 0.001 | |
| CHA2DS2-VASc score ≥ 2 | 39 (67.2) | 19 (54.3) | 0.281 | 0 (0) | 57 (100) | - | |
| Endpoint | 12 (20.7) | 9 (25.7) | 0.535 | 5 (13.9) | 16 (28.1) | 0.111 | |
| Cardiac death | 2 (3.4) | 0 (0) | 1 (2.8) | 1 (1.8) | |||
| HF administration | 2 (3.4) | 2 (5.7) | 1 (2.8) | 3 (5.3) | |||
| MVR or PMV | 4 (6.9) | 3 (8.6) | 2 (5.6) | 5 (8.8) | |||
| Stroke | 4 (6.9) | 4 (11.4) | 1 (2.8) | 7 (12.3) | |||
HF: heart failure, MVR: mitral valve replacement, PMV: percutaneous mitral valvuloplasty.
Data are shown as number (%).